Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy
- 1 February 1998
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 155 (1) , 60-67
- https://doi.org/10.1016/s0022-510x(97)00278-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Decreased 123I-MIBG uptake and increased clearance in various cardiac diseasesNuclear Medicine Communications, 1994
- Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neuronsAnnals of Neurology, 1994
- Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphyAmerican Heart Journal, 1993
- Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart.Heart, 1993
- Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidineDiabetes, 1992
- Autonomic cardiovascular reflexes in progressive supranuclear palsyJournal of the Autonomic Nervous System, 1992
- Cloning and functional characterization of a cocaine‐sensitive dopamine transporterFEBS Letters, 1991
- Effects of Levodopa and Bromocriptine on Blood Pressure and Plasma Catecholamines in ParkinsoniansClinical Neuropharmacology, 1991
- DEGENERATIVE DISEASES OF THE NERVOUS SYSTEM ASSOCIATED WITH AUTONOMIC FAILUREBrain, 1972
- ParkinsonismNeurology, 1967